TwitterLinkedin

Contact Us

  • Biopharma Excellence
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Current Opportunities
  • Training
Top Bar
Search
PharmaLex Logo
MENUMENU
  • PharmaLex Logo
  • PharmaLex Logo
  • About UsAbout Us
    • About Us
    • Management Team
    • Corporate Social Responsibility
    • What Our Clients Say About Us
  • Our Services
    • Discovery / Non-clinical
          • Go to Discovery / Non-clinical section >>

          • Strategy and Consulting

            • Integrated Product Development
            • Market Access
            • Scientific Advice
            • Statistics and Data Sciences
            • Toxicology Services
    • Clinical Development
          • Go to Clinical Development section >>

          • Strategy and Consulting

            • Clinical Program Development
            • Scientific Advice
            • Statistics and Data Sciences
          • Regulatory Affairs

            • Clinical Trial Applications
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Regulatory Operations
          • Pharmacovigilance

            • Clinical Trial Safety Support
            • Pharmacovigilance Consulting
          • Quality

            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
            • Tech Transfer / Scale-up
    • Authorization / Approval
          • Go to Authorization / Approval section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Regulatory Operations
            • Scientific, Regulatory and Technical Writing
            • Statistics and Data Sciences
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • Pharmacovigilance Consulting
          • Quality

            • Commercialization Readiness
            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • PAI Readiness
    • Post-approval / Maintenance
          • Go to Post-approval / Maintenance section >>

          • Strategy and Consulting

            • Market Access
          • Regulatory Affairs

            • CMC Services
            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Health Authority / Agency Interaction
            • Marketing and Labeling Activities
            • Mergers and Acquisitions (M&A) Transfers
            • Regulatory Operations
            • Toxicology Services
          • Pharmacovigilance

            • EU QPPV / National QPPV
            • ICSR (Individual Safety Case Report) Management
            • Literature Monitoring & Screening
            • Pharmacovigilance Quality & Compliance
            • Signal Management
          • Quality

            • Commissioning, Qualification, and Validation (CQV)
            • GxP Services
            • Interim / Contract QA
            • Quality Management Systems
          • Medical Affairs

            • Healthcare Compliance and Medical Approval
    • Program Management
          • Go to Program Management section >>

          • Program Management

            • Global End-to-End Outsourcing
            • Global Procedure Management
            • Integrated Product Development
            • Mergers and Acquisitions (M&A) Transfers
    • Featured Expertise
          • Industry Expertise

            • Biopharmaceuticals
            • MedTech Services
          • Service Expertise

            • ATMP / Cell and Gene Therapy
            • COVID-19 Support
            • GxP Services
            • Market Access
            • Pharmacovigilance Consulting
            • Post-Brexit Regulatory Support
            • Statistics and Data Sciences
            • SMARTPHLEX - technology-enabled services
  • Global ReachGlobal Reach
  • Contact usContact us
  • News & Events
    • Industry News Articles
    • Press Releases
    • Webinars
    • Events
    • Blog
    • Podcasts
  • Resource Library
    • Thought Leadership
    • Fact Flyers
    • Case Studies
    • White Papers
    • Webinars
    • Infographics
    • Video & Animation
  • Careers
    • Life at PharmaLex
    • Career Opportunities
  • Training
Home > Our Services > ICSR (Individual Safety Case Report) Management

ICSR (Individual Safety Case Report) Management

Confidence Beyond Compliance

The collection and processing of ICSRs are the most basic and important aspects of Pharmacovigilance system. PharmaLex delivers end-to-end ICSR Management solutions through our experts and services. PharmaLex offer the full range of ICSR Management Services from collection, triage, Data Entry ,Quality Review and Medical Review for regulatory submission of ICSRs.PharmaLex provide Safety Case Management services in various therapeutics areas and products in Pharmaceuticals, Radiopharmaceuticals, Nutraceuticals, Cosmetovigilance, Materiovigilance, Biologics / Biosimilars etc. :

  1. End-to-end Safety Case Management
  2. Cases Reconciliation
  3. SmartPHLEX solutions and Safety Databases

End-to-end Safety Case management

Individual Case Study Report (ICSR) plays an important role as it acts as a source of data in pharmacovigilance processes and activities.

End to end safety case managementEnd to end safety case management

Cases Reconciliation

Reconciliation of safety cases is performed as defined in Pharmacovigilance Agreements and contracts.

PharmaLex perform safety cases reconciliations with:

  • Company affiliates
  • Partners
  • Medical Information department
  • Product Complaints team
  • Clinical Trials

We ensure that the reconciliation process is performed between MAH and above-mentioned parties in a periodic manner or as defined in the respective PVAs (Pharmacovigilance Agreements), Safety Management Plans and other contracts.

SmartPHLEX solutions and Safety Databases

Automation, artificial intelligence (AI) and machine learning are revolutionizing many industries enabling increased productivity, improved quality and enhancing return on investment. The pharmaceutical industry is still largely relying on established, but increasingly outdated, systems and methodologies that were efficient many years ago yet now prove to be a limiting factor in innovation and growth. At PharmaLex we combine our extensive global experience and deep understanding of pharmaceutical lifecycle processes with the development of our cloud-based platform for life sciences automation alongside key partnerships with leading technology vendors. Through our pharma technology-enabled services we are helping our customers to adopt and take advantage of innovative technologies to drive efficiency gains within their own operations.

 

At PharmaLex we have the technology, know-how and experience to take these raw ingredients and realize real, immediate, and lasting benefits for our clients – we call this SmartPHLEX. 

  • SmartVigiscreen – managing EVWEB download cases: SmartVigiScreen is a cloud-based software solution that processes incoming ICSRs automating the analysis of company vs non-company cases and reducing screening workload significantly.

GxP validated system according to GAMP 5 guidelines and CFR Title 21 Part 11 compliant.

  • SmartVigicontract – Efficient management of PV contracts: SmartVigicontract is a cloud-based software solution for pharmacovigilance teams who need to handle large amounts of data deriving from contracts, such as Pharmacovigilance Agreements (PVAs) and Safety Data Exchange Agreements (SDEAs). The SmartVigicontract application serves as a single trusted source of information for generation of PVA overviews.

 

Safety Database: At PharmaLex our expert team in technology, consulting and operations support the entire pharmacovigilance journey including safety systems management, safety database migrations, etc.

  • PharmaLex has rich experience of working on multiple pharmacovigilance databases including those of our clients. Our processors have experience processing cases on variety of safety database, standard systems like Argus/ARISg/AB Cube / Veeva / PVNet / Basecon / BPI Pheda etc. and also on custom built in house proprietary safety databases.
  • For many clients, PharmaLex provide safety database solution. It has a fully validated E2B(R2/R3) compatible safety database for an end to end case processing services solution. For such customers, PharmaLex is completely responsible for the database management including provision of database, vendor management, computer system validation and change management, maintenance of configured settings (e.g. users, products), maintenance of related procedural documents. PharmaLex’ R&D Informatics team supports these activities, as well as database related user enquiries.
  • Our Safety database services also includes comprehensive support during the migration process from planning to quality control. PharmaLex holds scalable resources to perform (semi)manual migrations or conducts automated migrations together with database providers.
  • Safety databases are provided as part of PharmaLex’ service landscape including the provision of technology, vendor management, computer system validation and change management, maintenance of configured settings (e.g. users, products), maintenance of related procedural documents.
  • Our technology services include database provisioning, database management, advanced safety data reporting, analytics and insights.

Related News

Is quality documentation an asset or a burden in regulatory affairs?
Is quality documentation an asset or a burden in regulatory affairs?
6th April 2022
Can a robust QMS help you achieve customer satisfaction?
Can a robust QMS help you achieve customer satisfaction?
22nd September 2021
Signal detection – the complete guide
Signal detection – the complete guide
3rd August 2021

Related Resources

Thought Leadership

  • Can a robust QMS help you achieve customer satisfaction?
  • Product Launch
  • Quality Investigations & CAPAs "Elementary, my dear Watson"​

Fact Flyers

  • Signal Management Activities Customization
  • SMARTVIGILIT - Flyer
  • SMARTVIGICONTRACT - Flyer
  • SMARTVIGISCREEN - Flyer
  • Pharmacovigilance Services postcard

Case Studies

  • Case Processing Services
  • Support with retrieval of ICSR Follow-Up information
  • Global PV Outsourcing
  • Full PV Outsourcing of a Global Generics Pharma Company
  • Safety Detection and Signal Management
  • Development and Implementation of the Robustness Index
  • Continuous Manufacturing: Development, Optimization and Validation
  • Outsourcing pharmacovigilance activities to PharmaLex
  • Safety Writing Services
  • Aggregate Report Writing and RMPs
  • Remediation Activities and Operational Support
  • Business Readiness for new German Affiliate
  • Full service Post-Marketing Pharmacovigilance and Medical Information Services for large nutritional health company
  • Full service post-marketing and clinical trial PV activities for mid-sized pharma company
  • Dendritic cell vaccine (oncology)
  • Portfolio Maintenance Outsourcing – Global RA responsibility
  • Strategic outsourcing of mature product portfolio
  • Post–M&A PharmaLex program governance
  • Post–M&A pharma infrastructure development
  • Full PV service outsourcing

White Papers

  • Managing mature product portfolios - Key challenges and benefits
  • Inspection Readiness Audit - Gap Analysis - Mock Inspections
  • When your notified body is losing its designation under the medical device regulation
  • Top tips for a successful EU Orphan Drug Designation application
  • Tips for writing an outstanding Clinical Overview
  • The Medical Literature Monitoring of the EMA
  • Monitoring Compliance with Safety Exchange Agreements
  • Implementation of Eudravigilance Data Analysis System (EVDAS) in signal detection
  • QMS aspects of the Medical Device Regulation
  • Preparing for a Good Pharmacovigilance Practice MHRA Inspection
  • UK Pharmacovigilance Requirements Following the End of the Brexit Transition Period

Webinars

  • QbD – Analytical Quality by Design
  • Eudravigilance: overcoming challenges and gaining efficiencies with SMARTVIGISCREEN
  • QbD and Process Characterization
  • EudraVigilance – The fundamental tool for Pharmacovigilance
  • Vendor Management Programs - Ensuring Success!

Infographics

  • Virtual Auditing for GxP Compliance

Video & Animation

  • Using Technology-enabled Smart Services - what are the benefits?
  • SMARTPHLEX - Technology-enabled Smart Solutions
  • SMARTRISK - What is SMARTRISK

Related Services

  • Clinical Trial Safety Support
  • CMC Services
  • EU QPPV / National QPPV
  • Healthcare Compliance and Medical Approval
  • Literature Monitoring & Screening
  • MedTech Services
  • PAI Readiness
  • Pharmacovigilance Consulting
  • Pharmacovigilance Systems
  • Quality Management Systems
  • SMARTPHLEX
  • SMARTRISK
  • SMARTVIGICONTRACT
  • SMARTVIGILIT
  • SMARTVIGISCREEN
  • Tech Transfer / Scale-up
  • Virtual Audits

What our clients say

Thanks so much for your support over the past 30 days. Your commitment and timely communication have made working with you all a pleasant experience.

US Biotech
Senior QA Associate

They are available when we need to talk to them despite any time zone differentials

Japan based medium sized company
Manager

Want to find out more?

PharmaLex. Confidence beyond compliance.

Contact us for more information
Biopharma Excellence Website Image

PharmaLex Brings You Biopharma Excellence

Biopharma Excellence is a fusion of three scientific powerhouses, PharmaLex, ERA Consulting and Biopharma Excellence – all under the PharmaLex brand. This global team of scientific, regulatory and commercial professionals provide strategic product development and proactive regulatory services to developers of biopharmaceuticals, cell and gene therapies, monoclonal antibodies (MABs), vaccines and biosimilars.

Visit Website
USEFUL LINKS
  • Home
  • Contact us
  • Imprint
  • Data Protection
  • Terms and Conditions
RECENT TWEETS
VWVPlusVWVPlus@VWVPlus·
6 May

We're excited to announce that together with @PharmaLexGLOBAL, we're hosting a free webinar on the key manufacturing and supply chain issues for your #pharma business! Have questions at the ready as there will be time for an interactive Q&A: https://bit.ly/38W0vZe #legal

COVID-19 NEWSLETTER SIGN UP

SIGN UP NOW

WHAT OUR CLIENTS SAY
  • They are available when we need to talk to them despite any time zone differentials

    Japan based medium sized company
    Manager
PharmaLex
©2022 PharmaLex GmbH. All rights reserved.

ISO9001:2015 LogoEnergie Audit LogoSGS Logo

Suspicious Emails

We are aware of a number of suspicious emails about recruitment in circulation purporting to be from PharmaLex. Emails sent by PharmaLex will originate from @pharmalex.com. Should you receive an email and are unsure as to its validity, please report it to contact@pharmalex.com.

Many thanks for your understanding.

The PharmaLex Team

    Please DO NOT send us event/conference information.
    We will not respond and these will be deleted immediately.





    Select your state:

    .
    If you do not wish to receive any communication from us, you may unsubscribe at any time.

    #AskTheExpert #TogetherBEYONDCOVID19





      Select your state:

      .
      You can unsubscribe at any time at data.protection@pharmalex.com

      If you do not wish to receive any communication from us, you can unsubscribe at any time at. Click here to view our Privacy Policy.

      #TogetherBEYONDCOVID19

      We closely monitor developments and updates surrounding the current outbreak of Coronavirus Disease 2019 (COVID-19) from official sources including the World Health Organisation and are following the guidance and direction of the governments and the local authorities. We are taking this situation very seriously and our number one priority is the safety and business continuity for our customers and colleagues. As ever, we will do everything we can to ensure that services are delivered within the required time and the trusted quality PharmaLex is known for